On November 19, 2024, John Marotta, President and Chief Executive Officer of Azenta Life Sciences, purchased 13,967 shares of Azenta Inc (AZTA, Financial). Following this transaction, the insider now holds a total of 100,861.977 shares in the company. The details of this transaction can be found in the SEC Filing.
Azenta Inc is a company that provides life sciences solutions worldwide. The company offers a range of services and products, including sample management, genomic services, and automated storage systems, catering to the needs of the life sciences industry.
The insider's recent purchase is part of a broader trend observed over the past year, where there have been four insider buys and one insider sell within the company.
On the day of the purchase, Azenta Inc's shares were trading at $39.59, giving the company a market cap of $1.864 billion. The stock's GF Value is estimated at $74.83, resulting in a price-to-GF-Value ratio of 0.53, indicating that the stock is significantly undervalued according to GuruFocus metrics.
The GF Value is an intrinsic value estimate developed by GuruFocus, calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow. It also considers a GuruFocus adjustment factor based on the company’s past returns and growth, along with future estimates of business performance from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
